# High-Efficiency Three-Stroke Quantum Isochoric Heat Engine: From Infinite Potential Wells to Magic Angle Twisted Bilayer Graphene

Article · Hadi Mohammed Soufy, Colin Benjamin

- Archive id: arxiv:2511.13652
- Published: 2025-11-17
- Venue: Phys. Rev. E 113, 014126 (2026)
- DOI: https://doi.org/10.1103/z2c4-bdcn
- arXiv: https://arxiv.org/abs/2511.13652
- Citations: 0
- Source URL: https://arxiv.org/abs/2511.13652
- PDF: https://arxiv.org/pdf/2511.13652
- Provenance: arxiv

## Abstract

We introduce a three-stroke quantum isochoric cycle that functions as a heat engine operating between two thermal reservoirs. Implemented for a particle confined in a one-dimensional infinite potential well, the cycle's performance is benchmarked against the classical three-stroke triangular and isochoric engines. We find that the quantum isochoric cycle achieves a higher efficiency than both classical counterparts and also surpasses the efficiency of the recently proposed three-stroke quantum isoenergetic cycle. Owing to its reduced number of strokes, the design substantially lowers control complexity in nanoscale thermodynamic devices, offering a more feasible route to experimental realization compared to conventional four-stroke architectures. We further evaluate the cycle in graphene-based systems under an external magnetic field, including monolayer graphene (MLG), AB-stacked bilayer graphene (BLG), and twisted bilayer graphene (TBG) at both magic and non-magic twist angles. Among these platforms, magic-angle twisted bilayer graphene (MATBG) attains the highest efficiency at fixed work output, highlighting its promise for quantum thermodynamic applications.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Moire & 2D Superconductivity](https://space-kitty.com/topics/moire-superconductivity)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.